Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ): Price and Financial Metrics

Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ): $133.10

-0.73 (-0.55%)

POWR Rating

Component Grades













Add JAZZ to Watchlist
Sign Up

Industry: Biotech


of 505

in industry


  • JAZZ scores best on the Value dimension, with a Value rank ahead of 91.09% of US stocks.
  • The strongest trend for JAZZ is in Momentum, which has been heading down over the past 48 weeks.
  • JAZZ ranks lowest in Momentum; there it ranks in the 5th percentile.

JAZZ Stock Summary

  • JAZZ's current price/earnings ratio is 204.77, which is higher than 96.54% of US stocks with positive earnings.
  • With a year-over-year growth in debt of 206.79%, Jazz Pharmaceuticals plc's debt growth rate surpasses 95.73% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for JAZZ comes in at -55.17% -- higher than that of only 4.9% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Jazz Pharmaceuticals plc are STMP, SCOR, QGEN, LFUS, and ANIK.
  • Visit JAZZ's SEC page to see the company's official filings. To visit the company's web site, go to www.jazzpharma.com.

JAZZ Valuation Summary

  • In comparison to the median Healthcare stock, JAZZ's price/sales ratio is 72.69% lower, now standing at 3.1.
  • Over the past 174 months, JAZZ's price/sales ratio has gone down 5.8.
  • Over the past 174 months, JAZZ's EV/EBIT ratio has gone up 40.4.

Below are key valuation metrics over time for JAZZ.

Stock Date P/S P/B P/E EV/EBIT
JAZZ 2021-08-31 3.1 1.9 200.5 30.0
JAZZ 2021-08-30 3.1 1.9 200.3 30.0
JAZZ 2021-08-27 3.1 2.0 202.7 30.2
JAZZ 2021-08-26 3.1 2.0 202.4 30.2
JAZZ 2021-08-25 3.1 2.0 205.9 30.5
JAZZ 2021-08-24 3.2 2.0 207.7 30.6

JAZZ Growth Metrics

  • Its 3 year net income to common stockholders growth rate is now at 46.06%.
  • Its year over year revenue growth rate is now at 11.34%.
  • Its year over year price growth rate is now at 45.1%.
Over the past 33 months, JAZZ's revenue has gone up $774,933,000.

The table below shows JAZZ's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 2,625.797 770.852 40.164
2021-03-31 2,436.422 911.676 518.281
2020-12-31 2,363.567 899.648 238.616
2020-09-30 2,279.79 801.175 179.194
2020-06-30 2,216.604 880.789 133.236
2020-03-31 2,188.301 847.117 280.333

JAZZ's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • JAZZ has a Quality Grade of C, ranking ahead of 60.04% of graded US stocks.
  • JAZZ's asset turnover comes in at 0.32 -- ranking 142nd of 677 Pharmaceutical Products stocks.
  • REGN, AGLE, and NTLA are the stocks whose asset turnover ratios are most correlated with JAZZ.

The table below shows JAZZ's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.320 0.904 0.095
2021-03-31 0.380 0.934 0.196
2020-12-31 0.392 0.937 0.103
2020-09-30 0.395 0.941 0.076
2020-06-30 0.397 0.944 0.064
2020-03-31 0.402 0.944 0.073

JAZZ Price Target

For more insight on analysts targets of JAZZ, see our JAZZ price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $207.82 Average Broker Recommendation 1.38 (Strong Buy)

JAZZ Stock Price Chart Interactive Chart >

Price chart for JAZZ

JAZZ Price/Volume Stats

Current price $133.10 52-week high $189.00
Prev. close $133.83 52-week low $127.80
Day low $131.31 Volume 557,100
Day high $134.27 Avg. volume 708,255
50-day MA $144.75 Dividend yield N/A
200-day MA $162.61 Market Cap 8.17B

Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Company Bio

Jazz Pharmaceuticals is an international biopharmaceutical company with a diverse portfolio of products and/or product candidates with a focus in the areas of sleep and hematology/oncology. The company was founded in 2003 and is based in Dublin, Ireland.

JAZZ Latest News Stream

Event/Time News Detail
Loading, please wait...

JAZZ Latest Social Stream

Loading social stream, please wait...

View Full JAZZ Social Stream

Latest JAZZ News From Around the Web

Below are the latest news stories about Jazz Pharmaceuticals plc that investors may wish to consider to help them evaluate JAZZ as an investment opportunity.

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs

Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (NASDAQ: XLRN ) Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH ) C4 Therapeutics, Inc. (NASDAQ: CCCC ) Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE ) Corvus Pharmaceuticals, Inc. NASDAQ: CRVS) Fulcrum Therapeutics, Inc. (NASDAQ: FULC ) IVERIC bio, Inc. (NASDAQ: ISEE ) Leap Therapeutics, Inc. (NASDAQ: LPTX ) Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT ) Repligen Corporation (NASDAQ: RGEN ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 20) Ambrx Biopharma Inc. (NYSE: AMAM ) Absci Corporation (NASDAQ: ABSI ) Acutus Medical, Inc. (NASDAQ: AFIB ) Aytu Biopharma, Inc. (NASDAQ: AYTU ) AzurRx BioPharma, Inc. (NA...

Benzinga | September 22, 2021

September Sell-Off: 3 Dirt Cheap Growth Stocks to Buy

September's been a rough month for the stock market, and on Monday, the S&P 500 had its worst day in months, falling 1.7%. Instead, it may be time to load up on three growth stocks near their 52-week lows, including Jazz Pharmaceuticals (NASDAQ: JAZZ), Activision Blizzard (NASDAQ: ATVI), and Alibaba Group Holding (NYSE: BABA). Healthcare company Jazz Pharmaceuticals is trading at around $130 and has been falling more than 20% year to date, while the S&P 500 has risen by 16%.

Yahoo | September 22, 2021

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces Xywav (calcium, magnesium, potassium, and sodium oxybates) Investor Webcast on October 13, 2021

DUBLIN, Sept. 13, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Wednesday, October 13, 2021 at 4:30 p.m. ET / 9:30 p.m. IST t

FinanzNachrichten | September 13, 2021

Jazz Pharmaceuticals Announces Xywav® (calcium, magnesium, potassium, and sodium oxybates) Investor Webcast on October 13, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Wednesday, October 13, 2021 at 4:30 p.m. ET / 9:30 p.m. IST to provide an update on Xywav® (calcium, magnesium, potassium and sodium oxybates), the first and only U.S. Food and Drug Administration-approved treatment for idiopathic hypersomnia (IH) in adults, which was approved on August 12, 2021.

Yahoo | September 13, 2021

Are CBD Stocks Ready to Ride Again? (JAZZ, YCBD, NEPT, CVSI, MJNA, ALST)

Theres reason to believe the CBD market could come roaring back to prominence ahead given continued strong growth projections from key analysts. Companies like Neptune Wellness Solutions Inc (NASDAQ:NEPT), cbdMD Inc (NYSEAMERICAN:YCBD), Jazz Pharmaceuticals PLC (NASDAQ:JAZZ), Medical Marijuana Inc (OTC US:MJNA), Allstar Health Brands Inc (OTC US:ALST), and CV Sciences Inc (OTC US:CVSI) are all [] The post Are CBD Stocks Ready to Ride Again? (JAZZ, YCBD, NEPT, CVSI, MJNA, ALST) appeared first on Wall Street PR .

Wall Street PR | September 9, 2021

Read More 'JAZZ' Stories Here

JAZZ Price Returns

1-mo -0.04%
3-mo -25.07%
6-mo -19.43%
1-year -5.93%
3-year -20.84%
5-year 8.20%
YTD -19.36%
2020 10.56%
2019 20.43%
2018 -7.94%
2017 23.50%
2016 -22.43%

Continue Researching JAZZ

Here are a few links from around the web to help you further your research on Jazz Pharmaceuticals plc's stock as an investment opportunity:

Jazz Pharmaceuticals plc (JAZZ) Stock Price | Nasdaq
Jazz Pharmaceuticals plc (JAZZ) Stock Quote, History and News - Yahoo Finance
Jazz Pharmaceuticals plc (JAZZ) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.1549 seconds.